Cargando…
Pregnant with metastatic neuroendocrine tumour of the ovary: what now?
Neuroendocrine tumours (NET) are a heterogeneous group of neoplasms commonly occurring in the gastrointestinal tract or lungs but can occur in other regions. Primary ovarian NET account for 5% of all NET and 0.1% of all ovarian malignancies. In metastatic disease, the therapeutic goal is to extend s...
Autores principales: | Pistilli, B, Grana, CM, Fazio, N, Cavaliere, A, Ferrari, ME, Bodei, L, Baio, SM, Scambia, G, Paganelli, G, Peccatori, FA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273852/ https://www.ncbi.nlm.nih.gov/pubmed/22331988 http://dx.doi.org/10.3332/ecancer.2012.240 |
Ejemplares similares
-
Molecular identification of bronchopulmonary neuroendocrine tumours and neuroendocrine genotype in lung neoplasia using the NETest liquid biopsy
por: Filosso, Pier Luigi, et al.
Publicado: (2020) -
Institutional guidelines and ongoing studies in management of liver tumours: the experience of the European Institute of Oncology
por: Biffi, R, et al.
Publicado: (2008) -
Lessons from a multicentre retrospective study of peptide receptor radionuclide therapy combined with lanreotide for neuroendocrine tumours: a need for standardised practice
por: Prasad, Vikas, et al.
Publicado: (2020) -
Genomic alterations in neuroendocrine cancers of the ovary
por: Yaghmour, George, et al.
Publicado: (2016) -
Managing pregnant women with cancer: personal considerations and a review of the literature
por: Azim, HA, et al.
Publicado: (2011)